Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on AC Immune, Lowers Price Target to $15

SVB Leerink analyst Marc Goodman maintains AC Immune (NASDAQ:ACIU) with a Outperform and lowers the price target from $17 to $15.
byBenzinga Newsdesk
December 20, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Marc Goodman maintains AC Immune (NASDAQ:ACIU) with a Outperform and lowers the price target from $17 to $15.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts